Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Sponsor
Shahid Beheshti University of Medical Sciences
Study ID
NCT00370786
Phase
PHASE3
Status
Completed

Conditions

  • Choroidal Neovascularization

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc

Key Dates

First listed
Sep 1, 2006
Start date
Nov 30, 2005
Status verified
Jul 2008
Primary completion
Nov 30, 2007
Completion
Feb 29, 2008

Study Design

Enrollment
31 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 1

Primary Outcome Measure

Visual acuity [ Time Frame: 6 months ]

Related Studies